BackgroundGender influences the health and social risks faced by individuals initiating drug injecting. Using mixed methods across three settings in North America, we investigated the gender composition of injection initiation events and the gendered risk environments in which they occurred.MethodsThe PReventing Injecting by Modifying Existing Responses (PRIMER) study pooled data from three prospective community-recruited cohorts of people who inject drugs (PWID) in San Diego, USA, Vancouver, Canada, and Tijuana, Mexico. A qualitative subsample provided narrative data on their experiences of, and the contexts for, injection initiation events. Guided by Rhodes' risk environment framework, we examined the gender composition of initiation even...
Background: Persons who inject drugs (PWID) play a key role in assisting others' initiation into inj...
BackgroundInjection drug use remains a primary driver of HIV and HCV-related harms globally. However...
International audienceAbstractBackgroundInjection drug use remains a primary driver of HIV and HCV-r...
Abstract Aim Individuals experience differential risks in their initiation into drug injecting based...
AimIndividuals experience differential risks in their initiation into drug injecting based on their ...
Women's initiation into injection drug use often establishes a pattern of risk following first injec...
Background and objectives: Gender differences in illicit drug use patterns and related harms (e.g. H...
Background: Research demonstrates gender related differences in drug-use practices and risk behaviou...
Introduction and aimsHIV and hepatitis C virus transmission among people who inject drugs (PWID) is ...
Women who inject drugs (IDU) are at elevated risk for drug-related harms. While there has been growi...
ABSTRACT OF THE DISSERTATIONThe role of gender in experiences of substance use-related stigma and in...
ObjectivesPeople who inject drugs (PWID) play an integral role in facilitating the entry of others i...
BackgroundStudies of injection drug-using couples suggest a gendered performance of risk in which me...
Abstract Background Women who inject drugs (WWID) experience unique risks and adverse health outcome...
Background: Persons who inject drugs (PWID) play a key role in assisting others initiation into inje...
Background: Persons who inject drugs (PWID) play a key role in assisting others' initiation into inj...
BackgroundInjection drug use remains a primary driver of HIV and HCV-related harms globally. However...
International audienceAbstractBackgroundInjection drug use remains a primary driver of HIV and HCV-r...
Abstract Aim Individuals experience differential risks in their initiation into drug injecting based...
AimIndividuals experience differential risks in their initiation into drug injecting based on their ...
Women's initiation into injection drug use often establishes a pattern of risk following first injec...
Background and objectives: Gender differences in illicit drug use patterns and related harms (e.g. H...
Background: Research demonstrates gender related differences in drug-use practices and risk behaviou...
Introduction and aimsHIV and hepatitis C virus transmission among people who inject drugs (PWID) is ...
Women who inject drugs (IDU) are at elevated risk for drug-related harms. While there has been growi...
ABSTRACT OF THE DISSERTATIONThe role of gender in experiences of substance use-related stigma and in...
ObjectivesPeople who inject drugs (PWID) play an integral role in facilitating the entry of others i...
BackgroundStudies of injection drug-using couples suggest a gendered performance of risk in which me...
Abstract Background Women who inject drugs (WWID) experience unique risks and adverse health outcome...
Background: Persons who inject drugs (PWID) play a key role in assisting others initiation into inje...
Background: Persons who inject drugs (PWID) play a key role in assisting others' initiation into inj...
BackgroundInjection drug use remains a primary driver of HIV and HCV-related harms globally. However...
International audienceAbstractBackgroundInjection drug use remains a primary driver of HIV and HCV-r...